Silverback Therapeutics Inc. (SBTX) Social Stream
Silverback Therapeutics Inc (SBTX) Price Targets From Analysts
Use the tables below to see what analysts covering Silverback Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 76 days, SBTX's average price target has gone down $13.67.
Over the past 42 weeks, SBTX's average upside potential has been 121.44%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SBTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SBTX as an investment opportunity.
- In the context of all US stocks, Silverback Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 297.11% of them.
- To contextualize these metrics, consider that out of all US stocks, Silverback Therapeutics Inc's number of analysts covering the stock is higher than 37.44% of them.
- SBTX has a greater average analyst price target than 243.46% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Silverback Therapeutics Inc's variance in analysts' estimates is lower than -98.87% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Silverback Therapeutics Inc are RYTM, RXDX, and RPTX.
What is the outlook for SBTX? Use POWR Ratings for clearer insight into price direction.